High levels of osteopontin were reported in urine samples of patients with high-grade ovarian cancer, suggesting that the test could potentially be used as a non-invasive tool for the early diagnosis of ovarian cancer [42]. This evidence concerns the gene SPP1 and ovarian carcinoma.